Test Price
2,800 AED✅ Home Collection Available
SMARCA1 Gene X‑Linked Mental Retardation Genetic Test in UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑certified NGS processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (8 AM to 11 PM daily).
Clinical Guidance: Telephonic Post‑Test Genetic Counseling for precise result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced genetic test employs Next‑Generation Sequencing (NGS) to detect pathogenic variants in the SMARCA1 gene, a known cause of X‑linked intellectual disability. The assay covers all coding exons and flanking intronic regions to identify single nucleotide variants, small insertions/deletions, and copy number variants.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity, full gene coverage | ~95% sensitivity, targeted exons only |
| Methodology | Massively parallel NGS (Illumina® platform) | Chain‑termination sequencing |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Detection Scope | SNVs, indels, copy number variants | Limited to small mutations |
| Clinical Utility | Confirmatory diagnosis, carrier testing, family planning | Targeted mutation confirmation only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA ID: 9294403) — “The SMARCA1 NGS test provides definitive molecular diagnosis for X‑linked intellectual disability. Results must be correlated with clinical findings and family history. Our team supports families through genetic counseling and management pathways.”
Advisory
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. A genetic result does not replace ongoing clinical management; always discuss findings with your treating neurologist.
Exclusion Criteria & Red Flags
- Exclusion: Patients with severe coagulopathy that precludes safe blood draw, or inability to provide a viable DNA sample on FTA card.
- Exclusion: Minors must provide guardian consent in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Red Flag: If you experience sudden neurological deterioration, new‑onset seizures, or unexplained behavioral changes after receiving results, seek immediate emergency care.
- Red Flag: A positive result should be immediately discussed with a clinical geneticist; do not self‑interpret penetrance or variant significance.
Patient FAQ & Clinical Guidance
1. What is the SMARCA1 gene test and why is it important?
Snippet insight: The SMARCA1 NGS test detects mutations causing X‑linked intellectual disability, guiding precise clinical management and family planning.
This test analyzes the entire coding region of the SMARCA1 gene using high‑throughput sequencing. It identifies pathogenic variants linked to neurodevelopmental delay and cognitive impairment, enabling early intervention, genetic counseling, and informed reproductive decisions. Results are interpreted by board‑certified clinical geneticists and available in 3–4 weeks.
2. How is the test performed and what is the turnaround time?
Snippet insight: A simple blood draw or FTA card sample is collected at home by our VIP mobile phlebotomy team.
We dispatch a certified phlebotomist to your location between 8 AM and 11 PM. A single drop of blood on an FTA card, whole blood, or previously extracted DNA is accepted. The sample is transported in validated cold chain to our ISO‑certified laboratory. NGS sequencing and bioinformatics analysis require 3 to 4 weeks from sample receipt.
3. Is this covered by insurance in the UAE?
Snippet insight: Many UAE insurers cover genetic testing when medically indicated; we verify your coverage instantly via WhatsApp.
Contact our billing team on +971 54 548 8731 with your insurance card. We provide direct billing eligibility checks aligned with DHA and MOHAP regulations. Pre‑authorization for SMARCA1 testing typically requires a neurologist’s referral letter and family history documentation.
UAE Regulatory & Data Privacy Adherence
Data Protection Compliance: This test is performed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Clinical Safety: Patient consent and medical liability adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Facility Certification: DNA Labs UAE is an ISO 9001:2015 certified laboratory (Cert: INT/EGQ/2509DA/3139) operating under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | SMARCA1 Gene X‑Linked Mental Retardation Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood, FTA card, or extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina® platform |
| ICD-10-CM Code | Q99.8 (Other specified chromosomal abnormalities) |
| LOINC Code | 94727-5 (SMARCA1 gene mutation analysis in blood) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians